Viking Therapeutics Inc (VKTX)
41.23
-1.45
(-3.40%)
USD |
NASDAQ |
Dec 27, 12:35
Viking Therapeutics Research and Development Expense (Annual): 63.81M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen Inc | 4.784B |
| Eli Lilly and Co | 9.313B |
| Pfizer Inc | 10.68B |
| Merck & Co Inc | 30.53B |
| Vertex Pharmaceuticals Inc | 3.69B |